Key Insights

Highlights

Success Rate

88% trial completion (above average)

Published Results

36 trials with published results (17%)

Research Maturity

127 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.0%

17 terminated out of 213 trials

Success Rate

88.2%

+1.6% vs benchmark

Late-Stage Pipeline

22%

47 trials in Phase 3/4

Results Transparency

28%

36 of 127 completed with results

Key Signals

36 with results88% success17 terminated

Data Visualizations

Phase Distribution

143Total
Not Applicable (53)
Early P 1 (5)
P 1 (15)
P 2 (23)
P 3 (32)
P 4 (15)

Trial Status

Completed127
Recruiting27
Unknown21
Terminated17
Withdrawn9
Not Yet Recruiting6

Trial Success Rate

88.2%

Benchmark: 86.6%

Based on 127 completed trials

Clinical Trials (213)

Showing 20 of 20 trials
NCT03478852RecruitingPrimary

Investigating Epilepsy: Screening and Evaluation

NCT07228338Early Phase 1Not Yet Recruiting

Cholinergic Enhancement of Theta

NCT03233399Not ApplicableRecruitingPrimary

Modulating Movement Intention Via Cortical Stimulation

NCT05784805Not ApplicableRecruitingPrimary

Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients

NCT02216500Not ApplicableRecruitingPrimary

Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

NCT06534502Phase 4Not Yet RecruitingPrimary

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

NCT06129760Not ApplicableSuspended

Glioblastoma Remote Monitoring and Care - Research Protocol

NCT05339126Phase 2Active Not Recruiting

RNS System LGS Feasibility Study

NCT02813980Active Not Recruiting

Neural Circulatory Control and SUDEP Risk.

NCT07130786Phase 2RecruitingPrimary

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

NCT06401707Phase 2Recruiting

PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest

NCT05851391Phase 2Recruiting

buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest

NCT07721272Early Phase 1Not Yet Recruiting

Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation

NCT05864547Recruiting

Predisposing Factors for Post-stroke Epilepsy

NCT03419260RecruitingPrimary

Electrographic Seizure Management and Neurobehavioral Outcomes in Critically Ill Children

NCT05140265Recruiting

De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information

NCT05772429Active Not RecruitingPrimary

Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

NCT07125261Phase 1Active Not Recruiting

BHV-7000 Responsive Neurostimulation System (RNS) Study

NCT06714448Completed

A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia

NCT04770337Not ApplicableCompleted

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Scroll to load more

Research Network

Activity Timeline